Background
The report «Assessment of benefits and risks in probiotics in processed cereal-based baby foods Bifidobacterium lactis Bb12" was published by the Norwegian Scientific Committee for Food Safety (VKM) in May 2010.
The Norwegian Food Safety Authority (NFSA) has, based on previous assessments by the VKM, prohibited the sale of certain processed cereal-based foods for infants and young children containing probiotics.
After receiving a notification of three cereal-based foods for infants and young children and one infant formulae supplemented with Bifidobacterium lactis (2012), the NFSA sent a request (draft sent in December 2012) to the VKM to assess the safety and suitability of the bacterial strain. The assessment should be based on the latest scientific documentation submitted by the notifier. The notifier has provided documentation concerning the bacterial strain, including a confirmation on the probiotic effect, in addition to documentation on the safety and suitability of the bacterial strain for infants.
The formal request for the assessment of the bacterial strain and the use for infants, was sent from the NFSA to the VKM in December 2013. This assessment is requested on the basis of the requirements of safety and suitability given in the legislation for cereal-based baby foods and infant formulae and in the legislation for foods for particular nutritional needs.
Terms of reference
Translated from Norwegian terms of reference: 1) Based on the latest documentation, -is there any new scientific knowledge that gives grounds for reconsideration of the conclusions concerning safety in the report "Assessment of benefits and risks of probiotics in processed cereal-based baby foods Bifidobacterium lactis Bb12" or are the conclusions in the report still valid?
The documentation from the notifier also deals with the suitability of the bacterial strain.
2) Are infant formulae and cereal-based foods for infants and young children supplemented with Bifidobacterium lactis suitable for infants (from birth)?
Information provided by the applicant 2013
The producer has provided updated and new information about the bacterial strain and safety using these products intended for infants and small children.
Assessment of the new information
"Assessment of benefits and risks of probiotics in processed cereal-based baby foods supplemented Bifidobacteriumn lactis Bb12" from 2010 answered a request from the Norwegian Food Safety Authority focusing on the age groups 4-6 months, 6-12 months and 1-3 years. However, the use of infant formula intended for newborns, supplemented with this probiotic, was neither asked by the NFSA nor assessed by VKM.
The notifier of the baby foods intended for infants and small children has provided information on three different cereal-based products intended for age-groups over 4 months and one infant formula intended for newborns, all supplemented with B. lactis. In its letter the company concludes that their products supplemented with B. lactis do not pose any health and safety risk.
Regarding health effect, we have already mentioned in our assessment (Halvorsen et al. 2010) that: "It is not the mandate of this report to evaluate the health claims related to the products as these health claims are assessed by EFSA."
Our main conclusions regarding safety were as follows: The tet(W) gene in Bifidobacterium seems to be integrated in the chromosome and its surrounding regions vary depending on the strain, but very often the gene is flanked by transposase target sequences or genes coding for transposase, an enzyme that catalyzes the movement of DNA fragments between different locations by recognizing specific target sequences, suggesting that, under adequate conditions, the gene could be transferred (Gueimonde et al. 2013) . The presence of a tetracycline resistance gene, tet(W), flanked by a putative transposase gene in B. animalis subsp. lactis was also confirmed in other strains of Bifidobacterium than Bb12 (Stahl&Barrangou 2012).
Among the data provided by the notifier, we could not identify any new studies regarding the above mentioned concerns.
As already mentioned, our assessment from 2010 did not include probiotic-supplemented infant formula intended for use by newborns. It seems likely that the same concerns as for the cereal-based products will be valid in this age group and possibly of even greater importance. Our view is in accordance with these conclusions.
Conclusion
The notifier has not provided data answering concerns in our assessment of B. lactis Bb12 (Halvorsen et al. 2010) . We conclude that our concerns regarding safety have not been resolved and our conclusion from our assessment should be unchanged.
Konklusjon
Dokumentasjon fra melderen har ikke skaffet ny informasjon som kunne svare på bekymringer i VKMs vurdering av B. lactis Bb12 (Halvorsen et al. 2010) . VKM konkluderer med at bekymringer angående sikkerheten ikke har blitt løst, og konklusjon fra vår vurdering bør vaere uendret.
Answer to the questions
1. Based on the latest documentation, -is there any new scientific knowledge that gives grounds for reconsideration of the conclusions concerning safety in the report "Assessment of benefits and risks of probiotics in processed cereal-based baby foods Bifidobacterium lactis Bb12" or are the conclusions in the report still valid?
Information about the bacterial strain and safety provided by the producer represents no new knowledge that would change the conclusions of the assessment conducted 2010.
2. Are infant formulae and cereal-based foods for infants and young children supplemented with Bifidobacterium lactis suitable for infants (from birth)?
The Panel on biological hazards (FG1), has adopted "Assessment of probiotics in cereal based baby foods containing Bifidobacterium lactis Bb12 -update 2014" and concluded that there is no new information that could change the conclusion of the assessment prepared in 2010: groups, i.e. 4-6 months and 6-12 months, are in the most immature and vulnerable stage in terms of establishment of bacterial flora in the gut and the development of the immune system, and will therefore be the groups with the highest risk of any negative health effects from daily consumption of probiotics."
As the use of the infant formulae and processed cereal-based baby foods supplemented with Bifidobacterium lactis Bb12 was not assessed safe for the relevant age groups VKM concludes that the product is not suitable the same groups and the Panel on Nutrition, Dietetic Products, Novel Food and Allergy (FG7) will not assess the issue further.
